(Q44824859)

English

Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy

scientific article published in June 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sverre E. Kjeldsen

8

object named as

Kjeldsen SE

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Fossum E

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Olsen MH

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Høieggen A

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Wachtell K

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Reims HM

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ibsen H

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Julius S

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

375-380

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Selected major risk factors and global and regional burden of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Raised plasma-catecholamines in some patients with primary hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

A possible link between endothelial dysfunction and insulin resistance in hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

21 January 2018

Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Release and clearance rates of epinephrine in man: importance of arterial measurements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in plasma norepinephrine and endothelin levels and metabolic profile after AT1-receptor blockade in human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001712

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.JHH.1001712

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44824859&oldid=2206945376"